These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 24907065)
1. Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance. Schicchi N; Valeri G; Moroncini G; Agliata G; Salvolini L; Gabrielli A; Giovagnoni A Radiol Med; 2014 Dec; 119(12):885-894. PubMed ID: 24907065 [TBL] [Abstract][Full Text] [Related]
2. Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study. Gyllenhammar T; Kanski M; Engblom H; Wuttge DM; Carlsson M; Hesselstrand R; Arheden H BMC Cardiovasc Disord; 2018 Jan; 18(1):16. PubMed ID: 29382301 [TBL] [Abstract][Full Text] [Related]
3. Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis. Dumitru RB; Bissell LA; Erhayiem B; Fent G; Kidambi A; Swoboda P; Abignano G; Donica H; Burska A; Greenwood JP; Biglands J; Del Galdo F; Plein S; Buch MH Rheumatology (Oxford); 2021 Jun; 60(6):2934-2945. PubMed ID: 34080001 [TBL] [Abstract][Full Text] [Related]
9. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Di Cesare E; Battisti S; Di Sibio A; Cipriani P; Giacomelli R; Liakouli V; Ruscitti P; Masciocchi C Eur J Radiol; 2013 Jun; 82(6):e268-73. PubMed ID: 23510727 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis. Sano M; Satoh H; Suwa K; Nobuhara M; Saitoh T; Saotome M; Urushida T; Katoh H; Shimoyama K; Suzuki D; Ogawa N; Takehara Y; Sakahara H; Hayashi H Heart Vessels; 2015 Nov; 30(6):779-88. PubMed ID: 24996373 [TBL] [Abstract][Full Text] [Related]
11. Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. Mavrogeni S; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Raftakis J; Plastiras S; Noutsias M; Markousis-Mavrogenis G; Kolovou G BMC Cardiovasc Disord; 2017 Jul; 17(1):187. PubMed ID: 28716007 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset. Giacomelli R; Di Cesare E; Cipriani P; Ruscitti P; Di Sibio A; Liakouli V; Gennarelli A; Carubbi F; Splendiani A; Berardicurti O; Di Benedetto P; Ciccia F; Guggino G; Radchenko G; Triolo G; Masciocchi C Int J Rheum Dis; 2017 Sep; 20(9):1247-1260. PubMed ID: 28580766 [TBL] [Abstract][Full Text] [Related]
13. Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP. Bissell LA; Dumitru RB; Erhayiem B; Abignano G; Fent G; Kidambi A; Donica H; Burska A; Del Galdo F; Biglands J; Buckley DL; Greenwood JP; Plein S; Graham L; Buch MH Rheumatology (Oxford); 2019 Jul; 58(7):1221-1226. PubMed ID: 30690570 [TBL] [Abstract][Full Text] [Related]
14. Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis Patients. Mukherjee M; Chung SE; Ton VK; Tedford RJ; Hummers LK; Wigley FM; Abraham TP; Shah AA Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27266598 [TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401 [TBL] [Abstract][Full Text] [Related]
16. Detection of Left Ventricular Regional Dysfunction and Myocardial Abnormalities Using Complementary Cardiac Magnetic Resonance Imaging in Patients with Systemic Sclerosis without Cardiac Symptoms: A Pilot Study. Kobayashi Y; Kobayashi H; T Giles J; Yokoe I; Hirano M; Nakajima Y; Takei M Intern Med; 2016; 55(3):237-43. PubMed ID: 26831016 [TBL] [Abstract][Full Text] [Related]
17. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071 [TBL] [Abstract][Full Text] [Related]
18. Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test. Galea N; Rosato E; Gigante A; Borrazzo C; Fiorelli A; Barchetti G; Trombetta AC; Digiulio MA; Francone M; Catalano C; Carbone I PLoS One; 2020; 15(12):e0244282. PubMed ID: 33351821 [TBL] [Abstract][Full Text] [Related]
19. Myocardial fibrosis and arrhythmic burden in systemic sclerosis. Ross L; Costello B; Brown Z; Hansen D; Lindqvist A; Stevens W; Burns A; Prior D; Nikpour M; La Gerche A Rheumatology (Oxford); 2022 Nov; 61(11):4497-4502. PubMed ID: 35136975 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls". Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]